Home › Funds › Rangeley Capital, LLC › BCYC
Rangeley Capital, LLC position in BCYC
BICYCLE THERAPEUTICS PLC · Health Care
Rangeley Capital, LLC reported holding 253,500 shares of BCYC (BICYCLE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 1.02% of its reported portfolio and ranking #28 among its reported holdings. Rangeley Capital, LLC has disclosed BCYC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Rangeley Capital, LLC's BCYC position evolved
Rangeley Capital, LLC first disclosed a stake in BCYC in Q2 2025 at 75,000 shares (US$521K). The position peaked in Q1 2026 at 232,260 shares, worth US$1.1M. Across 5 filings, Rangeley Capital, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 253,500 shares valued at US$1.1M — an increase of 21,240 shares quarter over quarter.. Notable position changes include a 73% increase in Q3 2025 (shares fell 9% over the following quarter), a 76% increase in Q1 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 75.00K | $521.25K | New |
| Q3 2025 | 130.00K | $1.01M | Add |
| Q4 2025 | 132.00K | $934.56K | Add |
| Q1 2026 | 232.26K | $1.08M | Add |
| Q2 2026 | 253.50K | $1.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCYC and 13F data
BCYC (BICYCLE THERAPEUTICS PLC) is a Health Care company. 11 other funds we track also report a position in BCYC — the largest reported positions include BAKER BROS. ADVISORS LP (US$46.2M), FCPM III SERVICES B.V. (US$14.7M), Long Focus Capital Management, LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCYC
- BAKER BROS. ADVISORS LP 10.89M sh · $46.15M · Q2 2026
- FCPM III SERVICES B.V. 3.47M sh · $14.71M · Q2 2026
- Long Focus Capital Management, LLC 3.31M sh · $14.04M · Q2 2026
- GSK plc 1.53M sh · $6.49M · Q2 2026
More on Rangeley Capital, LLC
FAQ
How long has Rangeley Capital, LLC held BCYC?
Rangeley Capital, LLC has disclosed BCYC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Rangeley Capital, LLC's current position in BCYC?
As of Q2 2026, Rangeley Capital, LLC holds 253.50K shares of BCYC (BICYCLE THERAPEUTICS PLC), valued at $1.07M, representing 1.02% of its reported portfolio and ranking #28.
Has Rangeley Capital, LLC been buying or selling BCYC?
In the latest 13F filing (Q2 2026), Rangeley Capital, LLC increased its position in BCYC. The position peaked in Q1 2026 at 232.26K shares.
Which other funds hold BCYC?
Other major institutional holders of BCYC include BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., Long Focus Capital Management, LLC, among 11 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.